Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
So if I understand you correctly, a "correction" is effectively a reversion of the vascular dementia status of the patient? Is that right, DebKCardsPA?
If so, that would be a huge win for us. Biogen's market cap went up by several billion dollars when their drug showed a "slowdown" in Alzheimer's. I don't think there is any drug out there that has shown any such "correction" (if I am reading you right).
